Prof. Dr. İrfan Çiçin
Is this your profile? Claim it and verify your details.
Claim profileThe CV details on this page were translated automatically from the language of the source. See the original
Person ↔ Disease
Which diseases does this doctor work on?
-
Lung Neoplasms 43 publicationsSource: OpenAlex / PubMed MeSHView publications
- Carcinoma, Non-Small-Cell Lung 30 publications
- Breast Neoplasms 19 publications
- Kidney Neoplasms 13 publications
- Carcinoma, Renal Cell 12 publications
- Colorectal Neoplasms 11 publications
- Neoplasms 11 publications
- Liver Neoplasms 8 publications
- Brain Neoplasms 7 publications
- Ovarian Neoplasms 6 publications
- Neoplasms, Germ Cell and Embryonal 5 publications
- Carcinoma, Hepatocellular 5 publications
- Carcinoma, Squamous Cell 5 publications
- Colonic Neoplasms 5 publications
- Adenocarcinoma 5 publications
- Carcinoma, Transitional Cell 4 publications
- Urinary Bladder Neoplasms 4 publications
- Rectal Neoplasms 4 publications
- Diarrhea 4 publications
- Stomach Neoplasms 4 publications
- Urologic Neoplasms 3 publications
- Melanoma 3 publications
- Testicular Neoplasms 3 publications
- Carcinoma, Ductal, Breast 3 publications
- Breast Neoplasms, Male 3 publications
- Bone Neoplasms 3 publications
- Soft Tissue Neoplasms 3 publications
- Skin Neoplasms 3 publications
- Peritoneal Neoplasms 3 publications
- Neoplasms, Multiple Primary 2 publications
- Gallbladder Neoplasms 2 publications
- Heart Neoplasms 2 publications
- Carcinoma, Small Cell 2 publications
- Pneumonia 2 publications
- Weight Loss 2 publications
- Carcinoma, Lobular 2 publications
- Osteosarcoma 2 publications
- Pain 2 publications
- Adenocarcinoma of Lung 2 publications
- Kidney Diseases 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.
- Breast cancer
- Lung cancer
- Colorectal cancers
- Gynaecological and genitourinary cancers
- Molecular oncology
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologymedicalpark.com.trFrom source
- Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
- Institutionİstanbul Aydın Üniversitesi Medical Park Florya, Liv Hospital Topkapımedicalpark.com.trFrom source
- Area of workLung NeoplasmsExtracted from 43 publications · Model version —From source
- Publications318 publicationsOpenAlexFrom source
- ORCID0000-0002-7584-3868ORCIDFrom source
- Last synchronised4 November 2026 20:28https://www.medicalpark.com.tr/hekimler/irfan-cicinmedicalpark.com.tr
Scientific work
Publications on Lung Neoplasms
-
Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry
Anadolu Kliniği Tıp Bilimleri Dergisi, 2026
DOI 10.21673/anadoluklin.1675424 Open-access full textSource: OpenAlex
-
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors
JCO Global Oncology, 2026
DOI 10.1200/go-25-00234 PMID 41855443 Open-access full textSource: OpenAlex
-
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial
JTO Clinical and Research Reports, 2026
DOI 10.1016/j.jtocrr.2026.100988 PMID 42368479 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey
Scientific Reports, 2026
DOI 10.1038/s41598-026-61177-3 PMID 42414499 Open-access full textSource: OpenAlex
-
Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study
Journal of Clinical Oncology, 2026
DOI 10.1200/jco-25-00826 PMID 41538748 5 citations (Europe PMC) Open-access full textSource: OpenAlex
-
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer
JAMA Oncology, 2026
DOI 10.1001/jamaoncol.2026.1645 PMID 42240984 2 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Telemedicine adoption, pandemic-related fear, and treatment adherence in cancer care during COVID-19: a prospective cohort study
Supportive Care in Cancer, 2026
DOI 10.1007/s00520-026-10748-1 PMID 42081154 Open-access full textSource: OpenAlex
-
Continued Cemiplimab Beyond Progression With Addition of Chemotherapy in Patients With Advanced NSCLC With PD-L1 Expression of 50% or Higher: 5-Year Follow-Up From EMPOWER-Lung 1
JTO Clinical and Research Reports, 2026
DOI 10.1016/j.jtocrr.2026.101029 PMID 42529322 Open-access full textSource: OpenAlex
-
Investigating the feasibility of cascade genetic testing for BRCA1/2 in Türkiye: physicians' practices, barriers, and solutions
European Journal of Cancer Care, 2026
DOI 10.48130/ejcc-0026-0010 Source: OpenAlex
-
Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study
Clinics and Practice, 2026
DOI 10.3390/clinpract16090158 PMID 42783081 Open-access full textSource: OpenAlex